Atopia Therapeutics is a Geneva-based biotech startup developing a first-in-class oral immunomodulatory protein designed to restore immune balance in atopic diseases.
Our approach harnesses the body’s natural tolerance mechanisms to activate regulatory T cells (Tregs) and achieve durable immune reprogramming.
Atopia’s lead program targets allergic asthma and atopic dermatitis, with broader applications across immune-mediated disorders.
Address
GenevaSwitzerland
